Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,305 | 451 | 99.8% |
| Education | $11.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,178 | 80 | $0 (2024) |
| Amgen Inc. | $963.31 | 59 | $0 (2024) |
| Novo Nordisk Inc | $904.06 | 63 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $791.34 | 44 | $0 (2024) |
| Lilly USA, LLC | $751.63 | 55 | $0 (2024) |
| PFIZER INC. | $674.35 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $347.31 | 30 | $0 (2024) |
| Amarin Pharma Inc. | $245.07 | 13 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $172.68 | 7 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $163.33 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,242 | 57 | PFIZER INC. ($271.13) |
| 2023 | $1,368 | 80 | Amgen Inc. ($294.51) |
| 2022 | $1,059 | 51 | Amgen Inc. ($263.88) |
| 2021 | $907.61 | 58 | GlaxoSmithKline, LLC. ($162.25) |
| 2020 | $407.84 | 19 | SANOFI-AVENTIS U.S. LLC ($89.42) |
| 2019 | $1,835 | 156 | Novo Nordisk Inc ($349.83) |
| 2018 | $290.75 | 18 | GlaxoSmithKline, LLC. ($121.54) |
| 2017 | $206.13 | 13 | Merck Sharp & Dohme Corporation ($79.53) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: PAIN | ||||||
| 10/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: PAIN | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 999 | 3,840 | $509,411 | $137,910 |
| 2022 | 18 | 821 | 3,755 | $329,378 | $112,859 |
| 2021 | 16 | 1,035 | 3,234 | $211,633 | $104,878 |
| 2020 | 18 | 834 | 1,917 | $125,574 | $58,329 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 35 | 2,700 | $150,797 | $49,265 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 219 | 219 | $89,436 | $27,529 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 286 | $124,263 | $23,475 | 18.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 51 | 51 | $33,968 | $14,384 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 130 | $38,646 | $6,799 | 17.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $7,307 | $3,439 | 47.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 21 | $10,519 | $3,333 | 31.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $8,939 | $3,251 | 36.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 55 | 55 | $2,336 | $1,631 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $3,851 | $1,602 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $10,559 | $1,324 | 12.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 85 | $13,437 | $819.14 | 6.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $5,599 | $526.63 | 9.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 32 | 32 | $2,781 | $167.96 | 6.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 37 | 37 | $4,047 | $146.71 | 3.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 40 | $1,484 | $86.17 | 5.8% |
| G0405 | Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | Office | 2023 | 15 | 15 | $600.36 | $77.52 | 12.9% |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | Office | 2023 | 16 | 16 | $842.52 | $52.91 | 6.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 31 | 2,760 | $146,570 | $46,376 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 181 | 181 | $47,971 | $23,119 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 208 | $57,192 | $17,117 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 167 | $29,179 | $8,684 | 29.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 19 | 19 | $12,220 | $5,011 | 41.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 26 | $8,009 | $4,086 | 51.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $2,938 | $2,324 | 79.1% |
About Dr. Baby Than, MD
Dr. Baby Than, MD is a Family Medicine healthcare provider based in Woodstock, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033371554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Baby Than, MD has received a total of $7,317 in payments from pharmaceutical and medical device companies, with $1,242 received in 2024. These payments were reported across 452 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,305).
As a Medicare-enrolled provider, Than has provided services to 3,689 Medicare beneficiaries, totaling 12,746 services with total Medicare billing of $413,977. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Woodstock, IL
- Active Since 06/26/2008
- Last Updated 08/03/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033371554
Products in Payments
- TRELEGY ELLIPTA (Drug) $721.67
- FARXIGA (Drug) $569.31
- Otezla (Drug) $400.71
- Ozempic (Drug) $398.68
- ELIQUIS (Drug) $388.97
- MOUNJARO (Drug) $380.66
- JARDIANCE (Drug) $304.97
- NURTEC ODT (Drug) $276.39
- EVENITY (Biological) $272.34
- Vascepa (Drug) $245.07
- TRULICITY (Drug) $184.69
- ANORO (Drug) $157.55
- Rybelsus (Drug) $155.47
- Repatha (Biological) $145.87
- AIRSUPRA (Drug) $127.95
- Yupelri (Drug) $108.94
- CARTO 3 (Device) $108.80
- Aimovig (Biological) $102.51
- Tresiba (Drug) $91.83
- SOLIQUA 100/33 (Biological) $89.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Woodstock
Dr. James Lee, D.o, D.O
Family Medicine — Payments: $12,939
Dr. Kirk-Conrod Hewling, Md, MD
Family Medicine — Payments: $10,035
Dr. Scott Macleod, Md, MD
Family Medicine — Payments: $9,141
Dr. Lata Parvathaneni, Md, MD
Family Medicine — Payments: $7,525
Dr. Robert Hudec, Md, MD
Family Medicine — Payments: $7,139
Dr. Attri Datta, M.d, M.D
Family Medicine — Payments: $6,173